Insider · CIK 0001284500

TRABER PETER G

Reports to the SEC for 4 companies · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001284500

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-25	RNACCartesian Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−705 sh	$1.06	−$747.3	451,826
2023-01-05	RNACCartesian Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−20 sh	$1.11	−$22.228	446,121
2023-01-05	RNACCartesian Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,445 sh	$1.13	−$3,890.438	446,141
2023-01-04	RNACCartesian Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−15 sh	$1.14	−$17.13	449,586
2023-01-04	RNACCartesian Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−8,164 sh	$1.13	−$9,255.527	449,601
2023-01-02	RNACCartesian Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+200K sh	—	—	457,765
2023-01-02	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+900K sh	—	—	900,000
2022-01-10	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+65.4K sh	—	—	149,190
2022-01-05	RNACCartesian Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,226 sh	$3.09	−$9,955.113	251,355
2022-01-03	RNACCartesian Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+90.2K sh	—	—	254,581
2022-01-03	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+416K sh	—	—	415,900
2021-12-10	RNACCartesian Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,083 sh	$2.99	−$12.2K	164,381
2021-12-08	RNACCartesian Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+13.8K sh	—	—	168,464
2021-10-13	RNACCartesian Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,636 sh	$4.39	−$16K	154,714
2021-10-01	RNACCartesian Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+13.8K sh	—	—	158,350
2021-09-24	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+54.4K sh	—	—	54,400
2021-09-24	RNACCartesian Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+9,100 sh	—	—	144,600
2021-05-26	RNACCartesian Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+20K sh	$3.99	+$79.9K	135,500
2021-05-25	RNACCartesian Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+5,000 sh	$3.48	+$17.4K	115,500
2021-05-24	RNACCartesian Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+12.5K sh	$3.32	+$41.5K	110,500
2021-03-18	RNACCartesian Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$4.50	+$45K	98,000
2021-03-17	RNACCartesian Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+10K sh	$4.53	+$45.3K	88,000
2021-01-11	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+37.7K sh	—	—	83,760
2021-01-04	RNACCartesian Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+38K sh	—	—	78,000
2021-01-04	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+230K sh	—	—	230,000
2020-12-14	RNACCartesian Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+40K sh	$3.24	+$129K	40,000
2020-08-01	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+650K sh	—	—	650,000
2020-01-13	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+18.3K sh	$3.28	+$60K	46,025
2019-01-14	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+12.1K sh	$4.95	+$60K	27,733
2019-01-08	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+8,747 sh	—	—	15,612
2018-06-13	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	President & CEO	MExercise/Conversion	−100K sh	—	—	50,000
2018-06-13	GALTGALECTIN THERAPEUTICS INCS Sale	President & CEO	SSale	−100K sh	$7.51	−$751K	107,333
2018-06-13	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	President & CEO	MExercise/Conversion	+100K sh	$0.87	+$87K	207,333
2018-06-08	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)M Exercise/Conversion	President & CEO	MExercise/Conversion	−70K sh	—	—	150,000
2018-06-08	GALTGALECTIN THERAPEUTICS INCS Sale	President & CEO	SSale	−70K sh	$5.86	−$410K	107,333
2018-06-08	GALTGALECTIN THERAPEUTICS INCM Exercise/Conversion	President & CEO	MExercise/Conversion	+70K sh	$0.87	+$60.9K	177,333
2018-05-22	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	President & CEO	AAward	+125K sh	—	—	125,000
2018-01-15	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	President & CEO	AAward	+125K sh	—	—	125,000
2017-05-16	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+2,565 sh	—	—	6,865
2017-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+1,650 sh	—	—	4,300
2017-01-09	LSTALISATA THERAPEUTICS, INC. · Options to Purchase Common StockA Award	Director	AAward	+2,750 sh	—	—	2,750
2016-12-03	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	President & CEO	AAward	+220K sh	—	—	220,000
2016-06-22	LSTALISATA THERAPEUTICS, INC. · Options to Purchase Common StockA Award	Director	AAward	+12.5K sh	—	—	12,500
2016-06-22	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+7,500 sh	—	—	26,500
2016-01-25	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+9,000 sh	—	—	19,000
2016-01-25	LSTALISATA THERAPEUTICS, INC. · Options to Purchase Common StockA Award	Director	AAward	+15K sh	—	—	15,000
2016-01-20	GALTGALECTIN THERAPEUTICS INC · Stock option (right to buy)A Award	President & CEO	AAward	+134K sh	—	—	134,000
2015-08-12	GALTGALECTIN THERAPEUTICS INCP Purchase	President & CEO	PPurchase	+2,000 sh	$2.00	+$4,000	107,333
2015-06-02	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+10K sh	—	—	10,000
2015-06-01	GALTGALECTIN THERAPEUTICS INCP Purchase	President & CEO	PPurchase	+4,000 sh	$2.53	+$10.1K	105,333

Recent filings

Accepted (ET)
Sep 264
TRABER PETER G0001453687-23-000067
SEC(opens sec.gov)
Jan 64
TRABER PETER G0001453687-23-000032
SEC(opens sec.gov)
Jan 44
TRABER PETER G0001453687-23-000015
SEC(opens sec.gov)
Jan 124
TRABER PETER G0001284500-22-000003
SEC(opens sec.gov)
Jan 74
TRABER PETER G0001453687-22-000034
SEC(opens sec.gov)
Jan 54
TRABER PETER G0001453687-22-000025
SEC(opens sec.gov)
Dec 144
TRABER PETER G0001453687-21-000186
SEC(opens sec.gov)
Dec 104
TRABER PETER G0001453687-21-000176
SEC(opens sec.gov)
Oct 154
TRABER PETER G0001453687-21-000144
SEC(opens sec.gov)
Oct 54
TRABER PETER G0001453687-21-000135
SEC(opens sec.gov)
Sep 284
TRABER PETER G0001453687-21-000121
SEC(opens sec.gov)
May 274
TRABER PETER G0001453687-21-000078
SEC(opens sec.gov)
May 264
TRABER PETER G0001453687-21-000074
SEC(opens sec.gov)

Companies

Address

C/O PRO-PHARMACEUTICALS, INC. 7 WELLS AVENUE, SUITE 34

NEWTON, MA, 02459